Erlotinib-based doublet targeted therapy versus erlotinib alone in previously treated advanced non-small-cell lung cancer: a meta-analysis from 24 randomized controlled trials

por Gao, Jian-Wei, Zhan, Ping, Qiu, Xiang-Yu, Jin, Jia-Jia, Lv, Tang-Feng, Song, Yong
Publicado 2017